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PURPOSE. The aim of this study was to quantify epithelial, stromal, and endothelial cell density,
and subbasal nerve morphology in young patients with type 1 diabetes mellitus with and
without diabetic retinopathy.
METHODS. A total of 28 young patients (mean age, 22.86 6 9.05 years) with type 1 diabetes,
with (n ¼ 18) and without (n ¼ 10) retinopathy, and 17 age-matched healthy control subjects
(mean age, 26.53 6 2.43 years) underwent corneal confocal microscopy (CCM).
RESULTS. We found significantly lower epithelial (P < 0.0001) and endothelial (P ¼ 0.001) cell
densities and higher keratocyte cell density (P ¼ 0.024) in patients with type 1 diabetes
compared to controls. Significantly lower corneal nerve fiber density (P ¼ 0.004), nerve
branch density (P ¼ 0.004), total nerve branch density (P ¼ 0.04), and nerve fiber length (P
¼ 0.001), and greater nerve fiber width (P ¼ 0.04) were observed in patients with type 1
diabetes compared to control subjects. Significantly lower epithelial (P < 0.001) and
endothelial (P ¼ 0.02) cell densities, nerve branch density (P ¼ 0.02), and nerve fiber length
(P ¼ 0.04), and significantly higher keratocyte cell density (P ¼ 0.02) were found in patients
with type 1 diabetes without retinopathy compared to control subjects.
CONCLUSIONS. Corneal confocal microscopy identifies corneal cellular and small nerve fiber
pathology in young patients with type 1 diabetes without retinopathy, which increases in
severity in those with retinopathy. Corneal confocal microscopy appears to have considerable
use as an imaging biomarker for early subclinical pathology in young patients with type 1
diabetes mellitus.
Keywords: diabetic neuropathy, diabetic retinopathy, in vivo confocal microscopy, subbasal
corneal nerves, type 1 diabetes mellitus
The triad of retinopathy, nephropathy, and neuropathy arewell recognized microvascular complications, and are the
leading causes of premature blindness, end-stage renal failure,
foot ulceration, and amputation, respectively.1 Once estab-
lished, they have a major impact on the quality of life of
patients with diabetes and are associated with adverse health-
care outcomes.2 A major challenge is the early identification of
these complications to enable risk stratification and risk factor
reduction to prevent the development of the end-stage
complications.3
Diabetic retinopathy (DR) is strongly associated with
nephropathy,4 and is widely considered to be the most
common and earliest microvascular complication of diabetes.5
However, studies have shown that early neuronal abnormali-
ties, such as altered multifocal electroretinogram (mfERG)
responses,6 retinal nerve fiber layer thinning,7 and loss of
central visual field sensitivity,8 occur before the onset of overt
vascular lesions in the retina, and may be of prognostic value.
Recently, corneal nerve morphology assessed by corneal
confocal microscopy (CCM) has been proposed as an early
surrogate marker for small nerve fiber damage in diabetic
neuropathy.9,10 Corneal nerve fiber length correlates with
clinical and electrophysiological measures of diabetic periph-
eral neuropathy11,12 and long-term glycemic control.13,14
Furthermore, recent studies in adults with diabetes have shown
a stepwise deterioration in corneal nerve morphology in
healthy subjects and patients with preproliferative and prolif-
erative DR.15,16 Additionally, corneal lesions may develop in
patients with diabetes mellitus ranging from nonhealing
epithelial erosions to severe corneal ulceration and may be
related to underlying structural abnormalities.17
The onset and exact temporal relationship between neurop-
athy and retinopathy remains unclear. We have shown previously
that CCM can identify corneal nerve fiber loss in adults with type
1 diabetes without clinical neuropathy11,18 and, indeed, retinop-
athy or microalbuminuria.19 The purpose of this cross-sectional,
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observational study was to establish whether corneal cellular
and nerve alterations determined using CCM occur in young
patients with type 1 diabetes and whether they are associated
with the presence and severity of DR.
MATERIALS AND METHODS
Study Subjects
We studied 28 individuals (15 males and 13 females; mean age,
22.86 6 9.05 years) with type 1 diabetes mellitus and 17 age-
matched healthy subjects (9 males and 8 females; mean age,
26.53 6 2.43 years). Control subjects had no past or current
history of ocular disease and both groups had no history of
contact lens wearing or intraocular surgery. Patients with type
1 diabetes were divided into those without (18 patients; mean
age, 16.45 6 2.59 years) and with (10 patients; mean age,
32.51 6 5.99 years) retinopathy. Ophthalmologic examination
in diabetic patients included slit-lamp examination, dilated
fundus photography, IOP measurement, and CCM. The study
was performed in accordance with the tenets of the
Declaration of Helsinki and we obtained Local Ethical
Committee approval at the University of Debrecen. Informed
consent was obtained from all subjects. Children (under 18
years of age) were enrolled in the study after obtaining
informed consent from their parents or legal guardians.
Methods
After taking the medical history and visual acuity, CCM was
performed in all participants in both eyes using Heidelberg
Retina Tomograph III Rostock Cornea Module (HRT III RCM;
Heidelberg Engineering GmbH, Heidelberg, Germany). Genteal
Gel (0.3% hypromellose; Novartis Ophthalmics, East Hanover,
NJ, USA) was applied in a disposable sterile polymethylmetha-
crylate cap (Tomo-Cap; Heidelberg Engineering GmbH), which
was placed on the tip of the objective lens. A drop of local
anesthetic (tetracaine hydrochloride 0.4%) was administered to
both eyes and the subject was asked to fixate on a distant target
before commencing scanning of the central cornea. The
procedure took approximately 5 minutes to perform and none
of the subjects complained of pain, inconvenience, or visual
disturbance. All examinations were performed by a single
experienced examiner (ES). Section and volume scans of the
central cornea were recorded with the Heidelberg HRT-III
microscope, with 3843 384 pixels and a field of view of 4003
400 lm2. The right eyes of normal controls and diabetic
patients without retinopathy were used for analysis. In patients
with DR only the eligible eye (no previous intraocular surgery)
was used for analysis. Three good quality images (without
motion artifact) of the basal epithelium, posterior stroma,
endothelium, and subbasal nerve plexus were selected and
used for image analysis by the examiner (ES). The average of
three measurements was used for further comparative analysis.
Basal epithelium was defined as the first three clear scans
anterior to Bowman’s layer and the posterior stroma was
defined as the first three clear images immediately anterior to
Descemet’s membrane.20,21
For cell counting, the instrument-based software was used
which provided semiautomated cell density measurements. On
the epithelial, keratocyte, and endothelial cell scan, a region of
interest (ROI) was chosen that contained at least 50 cells, then
the cells were marked manually and the software automatically
calculated cell density (cells/mm2). A ROI area was 0.033 6
0.001 mm2 for the epithelium, 0.157 6 0.0005 mm2 for the
stromal layer, and 0.032 6 0.006 mm2 for the endothelium.
Subbasal nerve plexus morphology was quantified using
automated analysis software (ACCMetrics; University of Man-
chester, Manchester, UK).22 The following parameters were
quantified: nerve fiber density (NFD), the number of nerve
fibers/mm2; nerve branch density (NBD), the number of
primary branch points on the main nerve fibers/mm2; nerve
fiber length (NFL), the total length of nerves mm/mm2; nerve
fiber total branch density (TBD), the total number of branch
points/mm2; nerve fiber area (NFA), the total nerve fiber area
mm2/mm2; and nerve fiber width (NFW), the average nerve
fiber width mm/mm2.
Dilated fundus investigation was performed in all diabetic
patients. The International Clinical Diabetic Retinopathy
Disease Severity Scale23 was applied to classify the stage of
DR using fundus photographs: 0 ¼ no retinopathy, 1 ¼ mild
nonproliferative DR, 2 ¼ moderate nonproliferative DR, 3 ¼
severe nonproliferative DR, and 4 ¼ proliferative DR.
Statistical Analysis
Descriptive statistical results were described as mean, standard
deviation (SD), and 95% confidence interval (CI). Statistical
analysis was performed using MedCalc Version 10.2.0 and SPSS
13.0 for Windows. An ANOVA with post hoc Tukey test was
applied for comparison among three groups. For continuous
variables, Student’s t-test was used for comparing two groups;
for univariate analysis, the v2 test was used. For bivariate
correlation analysis, Pearson correlation test was used. A P
value 0.05 was considered statistically significant.
RESULTS
Patients’ characteristics and clinical data are detailed in Table 1.
There was no significant difference in mean age between
TABLE 1. Clinical Characteristics and Metabolic Data in Patients With Type 1 Diabetes Mellitus With and Without DR
Type 1 Diabetes Mellitus Patients
PWithout DR With DR
Duration of DM, y 5.79 6 2.58 21.56 6 6.38 <0.0001
HbA1c, % 7.91 6 0.94 (7.39–8.43) 9.38 6 3.2 (6.70–12.05) 0.11
HbA1c, mmol/mol 63.0 6 10.43 (57.23–68.77) 79.13 6 34.76 (50.06–108.19) 0.11
Cholesterol, mmol/L 4.02 6 0.83 (3.55–4.47) 5.56 6 1.11 (4.18–6.94) 0.004
Triglycerides, mmol/L 0.87 6 0.23 (0.74–0.99) 4.10 6 2.83 (0.59–7.61) 0.0002
HDL, mmol/L 1.75 6 0.27 (1.61–1.90) 0.92 6 0.51 (0.28–1.56) 0.0001
eGFR, mL/min/1.73 m2 > 90 in all patients 69.6 6 28.27 (45.99–93.26) 0.024
Hypertension 0/18 3/10 0.505
Microalbuminuria 0/18 2/10 0.478
Mean 6 SD (95% CI).
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patients with type 1 diabetes and controls (P ¼ 0.08). Of the
patients with type 1 diabetes, 15 had no retinopathy, while 2
had stage 2, 1 stage 3 and 7 stage 4 DR. Among individuals with
retinopathy, 9 patients (mean age, 31.26 6 4.52 years) had
undergone panretinal laser photocoagulation (PRP).
Corneal Cellular Alterations
Basal epithelial (P < 0.0001) and endothelial (P ¼ 0.001) cell
densities were significantly lower in patients with type 1
diabetes without and with retinopathy compared to control
subjects (Fig. 1, Table 2). Keratocyte cell density in the
posterior stroma was higher in patients with type 1 diabetes
compared to controls (P¼ 0.02). Basal epithelial (P < 0.0001)
and endothelial (P¼ 0.02) cell density was significantly lower,
and keratocyte cell density was greater (P ¼ 0.02) in patients
with type 1 diabetes without retinopathy compared to control
subjects. Epithelial (P ¼ 0.04) and endothelial (P¼ 0.004) cell
densities were lower in patients with type 1 diabetes with
retinopathy compared to patients without retinopathy.
Corneal Nerve Alterations
Significantly lower NFD (P¼0.004), NBD (P¼0.004), NFL (P¼
0.001), and TBD (P ¼ 0.04) values were observed in patients
with type 1 diabetes compared to healthy control subjects
(Figs. 2, 3; Table 3). There was no significant difference in NFA
among the three groups (P ¼ 0.144). Nerve fiber width was
significantly higher in patients with type 1 diabetes compared
to control subjects (P¼ 0.04). Post hoc analysis demonstrated
no significant difference in NFD (P¼ 0.256), but a lower NBD
(P¼ 0.02), and NFL (P¼ 0.04) in patients with type 1 diabetes
without retinopathy compared to control subjects. Nerve fiber
density (P¼ 0.003), NBD (P¼ 0.006), NFL (P¼ 0.001), NFW (P
¼ 0.03), and TBD (P ¼ 0.05) were all significantly lower in
patients with type 1 diabetes with retinopathy compared to
control subjects. There was a further significant reduction in
NFD (P¼ 0.03) in diabetes patients with compared to patients
without retinopathy.
There was a significant inverse correlation between NFD (r
¼0.428, P¼ 0.029) and NFL (r¼0.387, P¼ 0.046) with the
stage of retinopathy. The serum cholesterol level in patients
with type 1 diabetes correlated inversely with NFL (r¼0.511,
P ¼ 0.025) and NFW (r ¼0.450, P ¼ 0.047). There was no
significant correlation between the duration of diabetes,
hemoglobin A1c (HbA1c), serum triglycerides, high density
lipoprotein (HDL), and estimated glomerular filtration rate
(eGFR) with any of the morphologic parameters (P > 0.05).
DISCUSSION
The human cornea contains sensory nerve fibers originated
from the trigeminal nerve and sympathetic axons from the
superior cervical ganglion. Stromal nerve bundles enter the
cornea at its periphery and before penetrating Bowman’s
membrane, they compose the subepithelial plexus.24 After
dividing into several smaller branches, subbasal plexus nerves
innervate the corneal epithelium and form nerve terminals
with a considerably higher density in the central cornea than in
the periphery.24,25 Corneal nerves have a pivotal role in
maintaining the functional and morphologic integrity of the
ocular surface26 and serve protective and trophic functions. In
vivo corneal confocal microscopy has been used as a rapid,
noninvasive ophthalmic imaging technique to quantify the
cornea at the cellular level in several different pathologies.27,28
It has been applied widely in adults with diabetes and, indeed,
it has been shown to detect subclinical neuropathy,11,18 stratify
the severity of neuropathy,29 predict the development of
clinical neuropathy,30,31 and nerve repair after therapy.32 We
FIGURE 1. Basal epithelial cell count (A), keratocyte density (B), and endothelial cell density (C) measured with in vivo corneal confocal
microscopy in control subjects and patients with type 1 diabetes mellitus (T1DM) with and without retinopathy.
TABLE 2. Corneal Microstructural Alterations in Healthy Subjects Compared to Patients With Type 1 Diabetes Mellitus With and Without DR
Healthy Subjects
Type 1 Diabetes Mellitus Patients
P*Without DR P† With DR P†
Epithelial cell density, cells/mm2 9024.76 6 962.83
(8529.72–9519.8)
6942.73 6 881.04
(6504.6–7380.86)
<0.0001 5923.14 6 739.88
(5238.87–6607.42)
0.04 <0.0001
Keratocyte cell density, cells/mm2 268.84 6 40.09
(248.23–289.45)
314.11 6 52.98
(287.76–340.46)
0.02 289.13 6 44.85
(251.63–326.62)
0.258 0.024
Endothelial cell density, cells/mm2 3497.62 6 519.84
(3230.34–3764.9)
3250.36 6 421.49
(3007.0–3493.72)
0.02 2639.17 6 227.49
(2400.44–2877.9)
0.004 0.001
Mean 6 SD (95% CI).
* ANOVA among the three groups.
† Post hoc analysis comparing healthy subjects to type 1 diabetes patients without DR and type 1 diabetes patients without DR to patients with
DR.
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also have previously shown that corneal nerve abnormalities
occur in patients with type 119 and type 217 diabetes without
retinopathy and, therefore, may be the earliest of the
microvascular complications.
Studies in children and adolescents are limited, but we
recently have shown good reproducibility and usability of CCM
in young children with type 1 diabetes mellitus.33 Also in a
small pilot study of children with types 1 and 2 diabetes, we
previously showed no change in corneal nerve morphology
using corneal confocal microscopy.34 A recent study using
OCT in children with type 1 diabetes also has shown no
differences in the nerve fiber layer and ganglion cell layer.35
Quantitative sensory tests, such as vibration perception
thresholds and tactile perception thresholds, are inadequate
for screening early diabetic neuropathy in pediatric popula-
tions.36,37
Given that we and others have shown previously abnormal
corneal nerve morphology in adult diabetic patients without or
with minimal neuropathy,11,29,30 we have undertaken CCM in
young patients with type 1 diabetes. We demonstrate
widespread corneal microstructural alterations in these pa-
tients with type 1 diabetes without DR, which are worse in
those with retinopathy. Decreased basal epithelial and endo-
thelial cell density was observed and is similar to findings in
adults17,38 and children39 with diabetes. In our study,
keratocyte cell density in the posterior stroma was higher in
young patients with type 1 diabetes compared to controls. This
is in contrast with our previous study showing no significant
difference in posterior keratocyte cell density between healthy
subjects and adults with type 2 diabetes.40 The mechanism for
increased keratocyte density in these young patients with type
1 diabetes is unclear but a number of growth factors, including
fibroblast growth factor-2, insulin, and platelet-derived growth
factor-BB, have been shown to induce keratocyte prolifera-
tion.41 Additionally, a number of signal transduction pathways
are activated when diabetic keratocytes are cultured in Il-1a or
TNF-a, which may impact on cell proliferation and, hence,
density.42
We also demonstrated in particular lower corneal nerve
branch density and length, in young diabetic patients without
retinopathy or microalbuminuria, confirming previous studies
in adults with type 1 and type 2 diabetes.17,19 Furthermore,
automated analysis has enabled us to identify lower total
branch density, confirming early more distal loss of nerve
branches with greater NFW, consistent with this loss of thinner
more distal branches. Interestingly, total nerve fiber area was
comparable between control subjects and diabetic patients,
presumably due to the early relative preservation of main nerve
fibers with a primary reduction in nerve branches. In the
present study, there was a significant association between the
corneal nerve alterations and the presence and severity of
retinopathy, confirming previous studies.17,19,43
A limitation of this study is that we did not screen
participants for other causes of neuropathy. Therefore, it is
possible, although unlikely in this young population, that some
participants may have had a neuropathy from a cause other
than diabetes, potentially confounding our data.
FIGURE 3. Nerve fiber density (A), NBD (B), NFA (C), NFL (D), TBD (E), NFW (F) in control subjects and patients with type 1 diabetes mellitus
(T1DM) with and without retinopathy.
FIGURE 2. Annotated image of the subbasal nerve plexus using
ACCMetrics software (red, fiber; blue, branch; green, branch point).
(A) normal nerve fiber morphology of a healthy individual. (B)
Decreased nerve fiber density and altered morphology of a patient
with type 1 diabetes mellitus for 10 years without retinopathy (HbA1c,
9.8%, 84 mmol/mol). (C) Subbasal nerve damage in a patient with type
1 diabetes mellitus for 27 years and Grade 4 retinopathy (HbA1c, 8.7%,
72 mmol/mol).
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In conclusion, in vivo CCM appears to be a valuable,
noninvasive ophthalmic imaging tool for identifying early
corneal cellular and nerve fiber pathology in young patients
with type 1 diabetes mellitus, before the development of DR.
This adds to the weight of evidence suggesting that CCM has
considerable potential in identifying early subclinical patholo-
gy in patients with type 1 diabetes.
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